Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Graff

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
Lancet Regional Health. Americas|March 9, 2026
Renal cell carcinoma incidence and mortality in California: a population-based study of sociodemographic patterns and temporal trends from 1988 through 2019Kevin L'Espérance, Katherine Lin, Daphne Lichtensztajn, et al.
BMC Medicine|October 5, 2022
Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studiesTaylor B Cavazos, Linda Kachuri, Rebecca E Graff, et al.
The Prostate|March 3, 2015
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancerRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
International Journal of Cancer|July 19, 2019
Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancerDana Hashim, Amparo G Gonzalez-Feliciano, Thomas U Ahearn, et al.
Cancer Causes & Control : CCC|January 17, 2026
Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trialWilliam A Pace, Adam Olshen, Ye Wang, et al.
Research Square|June 5, 2026
Cross-population metabolome-wide Mendelian randomization study of prostate cancer riskHarriett Fuller, Rebecca Rohde, Heather M Highland, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 2017
Height, Obesity, and the Risk of <i>TMPRSS2:ERG</i>-Defined Prostate CancerRebecca E Graff, Thomas U Ahearn, Andreas Pettersson, et al.
European Urology|October 11, 2018
A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERGClaire H Pernar, Ericka M Ebot, Andreas Pettersson, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Identification of Antituberculars with Favorable Potency and Pharmacokinetics through Structure-Based and Ligand-Based ModelingVedang Warapande, Fanwang Meng, Alexandra Bozan, et al.
Journal of the National Cancer Institute|December 3, 2013
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERGAndreas Pettersson, Rosina T Lis, Allison Meisner, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Lancet Regional Health. Americas|March 9, 2026
Renal cell carcinoma incidence and mortality in California: a population-based study of sociodemographic patterns and temporal trends from 1988 through 2019Kevin L'Espérance, Katherine Lin, Daphne Lichtensztajn, et al.
BMC Medicine|October 5, 2022
Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studiesTaylor B Cavazos, Linda Kachuri, Rebecca E Graff, et al.
The Prostate|March 3, 2015
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancerRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
International Journal of Cancer|July 19, 2019
Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancerDana Hashim, Amparo G Gonzalez-Feliciano, Thomas U Ahearn, et al.
Cancer Causes & Control : CCC|January 17, 2026
Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trialWilliam A Pace, Adam Olshen, Ye Wang, et al.
Research Square|June 5, 2026
Cross-population metabolome-wide Mendelian randomization study of prostate cancer riskHarriett Fuller, Rebecca Rohde, Heather M Highland, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 2017
Height, Obesity, and the Risk of <i>TMPRSS2:ERG</i>-Defined Prostate CancerRebecca E Graff, Thomas U Ahearn, Andreas Pettersson, et al.
European Urology|October 11, 2018
A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERGClaire H Pernar, Ericka M Ebot, Andreas Pettersson, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Identification of Antituberculars with Favorable Potency and Pharmacokinetics through Structure-Based and Ligand-Based ModelingVedang Warapande, Fanwang Meng, Alexandra Bozan, et al.
Journal of the National Cancer Institute|December 3, 2013
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERGAndreas Pettersson, Rosina T Lis, Allison Meisner, et al.
Pageof 22